Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-04-30 | 2021-05-17 | 138349 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-12-17 | 2022-03-29 | 151345 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-02-16 | 2023-04-04 | 185042 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-04-06 | 2023-07-13 | 188982 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-05-26 | 2023-07-13 | 193230 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-06-09 | 2023-07-13 | 194564 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-01 | 2024-02-09 | 203542 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-09-22 | 2023-12-08 | 204993 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-11-10 | 2023-12-08 | 209926 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-02-02 | 2024-06-27 | 218379 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-04-12 | 2024-06-27 | 224987 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-04-26 | 2025-03-07 | 226348 |
| APO-MELOXICAM | 15MG | TABLET | Resolved | 2024-05-31 | 2024-06-07 | 229422 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-06-27 | 2025-09-19 | 231487 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2024-08-29 | 2025-03-21 | 236240 |
| APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2024-09-12 | 2024-10-11 | 237357 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2025-02-06 | 2025-11-20 | 249746 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2025-05-01 | 2025-07-11 | 256322 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2025-06-26 | 2025-09-12 | 261164 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |